The current recommendation of Hold for Zimmer Biomet Holdings, Inc. (NYSE:ZBH) has been derived by using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. ZBH has been upgraded from a Sell to a Hold in the last week.

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) is a $25.2 billion in market value component of the Health Care Equipment & Supplies GICS industry group where The current Portfolio Grader ranking for ZBH puts it 102 among the 163 companies in this industry group, which is a below-average position. ZBH is ranked in the third quartile of the sector with a ranking of 447 among the 783 companies in the sector and number 3,019 in the 5000 company Portfolio Grader company universe.

As one of the 782 companies in the GICS Health Care sector Zimmer Biomet Holdings, Inc. (NYSE:ZBH) is a component of the 163 company Health Care Equipment & Supplies GICS industry group within this sector. ZBH has a market value of $24.7 billion which is in the top 10% of its industry group. The current Portfolio Grader ranking for ZBH puts it 114 among the 163 companies in this industry group, giving it a lower than average position; in the third quartile of the sector with a ranking of 522 among the 782 companies in the sector, and number 3,481 in the nearly 5,000 company Portfolio Grader universe.

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) is one of the 783 companies in the GICS Health Care sector, and a constituent of the 162 company Health Care Equipment & Supplies GICS industry group within this sector. The market value of ZBH is $24.2 billion which places it in the top decile in its industry group. The current Portfolio Grader ranking for ZBH puts it 114 among the 162 companies in this industry group, which is a below-average position; in the third quartile of the sector with a ranking of 521 among the 783 companies in the sector, and number 3,460 in the nearly 5,000 company Portfolio Grader universe.

The current recommendation of Sell for Zimmer Biomet Holdings, Inc. (NYSE:ZBH) is computed using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. The current Portfolio Grader recommendation on the shares has been in place for 2 months.